Log in
Enquire now

List of OtiTopic patents

List of OtiTopic patents
List of Autonet Mobile patents
List of Rothamsted Research patents
List of Spirit AeroSystems patents
List of funding rounds for UJET
List of awards received by Sam Elliott
Patents where
Current Assignee
Name
is
‌
OtiTopic
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9757395 Dry powder inhaler and methods of use

Patent 9757395 was granted and assigned to OtiTopic on September, 2017 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
9757395
September 12, 2017
‌
US Patent 9757529 Dry powder inhaler and methods of use

Patent 9757529 was granted and assigned to OtiTopic on September, 2017 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
9757529
September 12, 2017
‌
US Patent 10195147 Dry powder compositions with magnesium stearate

Patent 10195147 was granted and assigned to OtiTopic on February, 2019 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
10195147
February 5, 2019
‌
US Patent 11077058 Dry powder compositions with magnesium stearate

Patent 11077058 was granted and assigned to OtiTopic on August, 2021 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
11077058
August 3, 2021
‌
US Patent 10149823 Dry powder formulations and methods of use

Patent 10149823 was granted and assigned to OtiTopic on December, 2018 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
10149823
December 11, 2018
‌
US Patent 9993488 Dry powder formulations for inhalation

Patent 9993488 was granted and assigned to OtiTopic on June, 2018 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
9993488
June 12, 2018
‌
US Patent 10568894 Dry powder formulations for inhalation

Patent 10568894 was granted and assigned to OtiTopic on February, 2020 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
10568894
February 25, 2020
‌
US Patent 11160815 Dry powder formulations for inhalation

Patent 11160815 was granted and assigned to OtiTopic on November, 2021 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
11160815
November 2, 2021
‌
US Patent 10772832 Dry powder formulations for inhalation

Patent 10772832 was granted and assigned to OtiTopic on September, 2020 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
10772832
September 15, 2020
‌
US Patent 10813881 Dry powder inhalation device

Patent 10813881 was granted and assigned to OtiTopic on October, 2020 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
10813881
October 27, 2020
‌
US Patent 10786456 Inhaled aspirin and magnesium to treat inflammation

Patent 10786456 was granted and assigned to OtiTopic on September, 2020 by the United States Patent and Trademark Office.

‌
OtiTopic
‌
OtiTopic
United States Patent and Trademark Office
United States Patent and Trademark Office
10786456
September 29, 2020
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us